Analysis of the best secondary metabolite compound of binahong leaves (

Subclinical mastitis is a disease that causes inoptimal milk production and milk quality. Subclinical mastitis can be treated with the help of herbal plants. Binahong leaf (Anredera cordifolia (Ten.) Steenis) is one of the herbals that contains several antibacterial secondary metabolite compounds. This study aims to identify the secondary metabolite of binahong leaf extract that has the best antibacterial activity against bacteria that cause subclinical mastitis. The herbal ingredient used was binahong leaf extract, and the bacterium that causes mastitis was S. epidermidis. The analyses used were TLC bioautography. The data were analyzed descriptively. The results showed that the growth of S. epidermidis could be inhibited by binahong leaf extract with an inhibition zone of 11 mm identified in the fraction with an Rf value of 0.95. The fraction was a triterpenoid compound marked purple after being sprayed with Lieberman burchard. It can be concluded that the best secondary metabolite compound in binahong leaf extract is triterpenoid. Triterpenoid in binahong leaf extract at Rf 0.95 showed the best activity in inhibiting the growth of S. epidermidis as one of the bacteria that causes subclinical mastitis with an inhibitory zone of 11 mm.

Authors

Publication Details

Journal
Springer Link (Chiba Institute of Technology)
Published
2025-04-04
DOI
https://doi.org/10.1051/bioconf/202517101003/pdf
Primary Topic
Medicinal Plant Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of the best secondary metabolite compound of binahong leaves (

Idat Galih Permana, Eni Siti Rohaeni, Dwierra Evvyernie Amirroenas, Tri Wahyu Apriliana et al.
Springer Link (Chiba Institute of Technology)
Medicinal Plant Research
article

Analysis of the best secondary metabolite compound of binahong leaves (

Idat Galih Permana, Eni Siti Rohaeni, Dwierra Evvyernie Amirroenas, Tri Wahyu Apriliana, Despal
article en

Abstract

Subclinical mastitis is a disease that causes inoptimal milk production and milk quality. Subclinical mastitis can be treated with the help of herbal plants. Binahong leaf (Anredera cordifolia (Ten.) Steenis) is one of the herbals that contains several antibacterial secondary metabolite compounds. This study aims to identify the secondary metabolite of binahong leaf extract that has the best antibacterial activity against bacteria that cause subclinical mastitis. The herbal ingredient used was binahong leaf extract, and the bacterium that causes mastitis was S. epidermidis. The analyses used were TLC bioautography. The data were analyzed descriptively. The results showed that the growth of S. epidermidis could be inhibited by binahong leaf extract with an inhibition zone of 11 mm identified in the fraction with an Rf value of 0.95. The fraction was a triterpenoid compound marked purple after being sprayed with Lieberman burchard. It can be concluded that the best secondary metabolite compound in binahong leaf extract is triterpenoid. Triterpenoid in binahong leaf extract at Rf 0.95 showed the best activity in inhibiting the growth of S. epidermidis as one of the bacteria that causes subclinical mastitis with an inhibitory zone of 11 mm.

Springer Link (Chiba Institute of Technology)
Openalex Percentile: Top 21%
Medicinal Plant Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Analysis of the best secondary metabolite compound of binahong leaves ( — Idat Galih Permana, Eni Siti Rohaeni, et al. · Springer Link (Chiba Institute of Technology) (2025) | TGRS Research Map | TGRS